Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
The trial of a personal injury lawsuit filed against C.R. Bard over its Avaulta pelvic mesh ends in a mistrial today. The trial of a personal injury lawsuit filed against C.R. Bard (NYSE:BCR) ended in mistrial today after a federal judge granted Bard’s motion to dismiss, according to court documents. Judge Joseph Goodwin declared a mistrial at 2:15 p.m. today, according to the documents, during the 2nd day of the trial. Goodwin halted the trial after witness Lennox Hoyte referred to Bard’s marketing of the devices; the judge had barred any reference to Bard’s decision to pull the transvaginal mesh product off the market last year.
Help employers find you! Check out all the jobs and post your resume.
